A citation-based method for searching scientific literature

Thomas Powles, Joseph Paul Eder, Gregg D Fine, Fadi S Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A Burris, Daniel P Petrylak, Siew-leng Teng, Xiaodong Shen, Zachary Boyd, Priti S Hegde, Daniel S Chen, Nicholas J Vogelzang. Nature 2014
Times Cited: 1709



Padmanee Sharma, Margaret K Callahan, Petri Bono, Joseph Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi N Pillai, Patrick A Ott, Filippo de Braud, Michael Morse, Dung T Le, Dirk Jaeger, Emily Chan, Chris Harbison, Chen-Sheng Lin, Marina Tschaika, Alex Azrilevich, Jonathan E Rosenberg. Lancet Oncol 2016
Times Cited: 443




List of shared articles



Times cited

Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, Funda Meric-Bernstam, Nathaniel Wilson, Aung Naing, Sarina Piha-Paul, Filip Janku, Shubham Pant, Timothy A Yap,[...]. Clin Genitourin Cancer 2022
0

MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, Yang Lu, Qi Wang, Sumankalai Ramachandran, Rebecca Slack Tidwell, Guangchun Han, Xinmiao Yan, Jieru Meng,[...]. Nat Commun 2022
4

Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management.
Joaquim Bellmunt, Begoña P Valderrama, Javier Puente, Enrique Grande, M Victoria Bolós, Nuria Lainez, Sergio Vázquez, Pablo Maroto, Miguel Ángel Climent, Xavier Garcia Del Muro,[...]. Crit Rev Oncol Hematol 2022
3

The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma.
Richard Cathomas, Anja Lorch, Harman M Bruins, Eva M Compérat, Nigel C Cowan, Jason A Efstathiou, Rainer Fietkau, Georgios Gakis, Virginia Hernández, Estefania Linares Espinós,[...]. Eur Urol 2022
31

Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer.
Kecheng Lou, Shangzhi Feng, Guoxi Zhang, Junrong Zou, Xiaofeng Zou. Front Oncol 2022
1


Insights on recent innovations in bladder cancer immunotherapy.
Mohamed A Abd El-Salam, Claire E P Smith, Chong-Xian Pan. Cancer Cytopathol 2022
2

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future.
Zhengchao Zhang, Dong Li, Heng Yun, Wei Liu, Keqiang Chai, Jie Tong, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie. Front Oncol 2022
0

Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer.
Zheng Zhu, Ai-Hong Ma, Hongyong Zhang, Tzu-Yin Lin, Xiangdong Xue, Hizra Farrukh, Shaoming Zhu, Wei Shi, Ruan Yuan, Zhixiu Cao,[...]. Clin Cancer Res 2022
0

Radiopharmaceuticals as Novel Immune System Tracers.
Natalie A Ridge, Anne Rajkumar-Calkins, Stephanie O Dudzinski, Austin N Kirschner, Neil B Newman. Adv Radiat Oncol 2022
0